Rhythm's Imcivree Launch in Hypothalamic Obesity Encouraging, RBC Says
MT newswire2026/10/08 15:1511:15 AM EDT, 10/08/2026 (MT Newswires) -- Rhythm Pharmaceuticals' (RYTM) early Imcivree feedback from four pediatric endocrinologists managing hypothalamic obesity patients is encouraging, RBC said in a note Thursday. RBC analysts said they spoke with the four key opinion leaders, who collectively have over 40 hypothalamic obesity patients, to assess the early launch of Imcivree. "Our conversations were constructively encouraging," the report said, adding that three of the four KOLs already have patients on Imcivree and three also expect to increase their use of the drug. All four viewed Imcivree favorably, the report said. Based on the feedback, RBC analysts raised their estimated peak HO penetration to 20% from 15% and peak sales estimate to $1.5 billion from $1.3 billion. RBC raised its price target to $159 from $155 and reiterated its outperform rating with speculative risk. Price: 87.97, Change: -0.48, Percent Change: -0.54
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
Crypto prices
More
